Next Article in Journal
The Impact of Impulsivity on Weight Loss Four Years after Bariatric Surgery
Next Article in Special Issue
Causes, Consequences and Public Health Implications of Low B-Vitamin Status in Ageing
Previous Article in Journal
What Do People Know and Believe about Vitamin D?
Previous Article in Special Issue
Organ-Specific Gene Expression Changes in the Fetal Liver and Placenta in Response to Maternal Folate Depletion
Article Menu

Export Article

Open AccessReview
Nutrients 2016, 8(11), 720;

Novel Approaches to Investigate One-Carbon Metabolism and Related B-Vitamins in Blood Pressure

Northern Ireland Centre for Food and Health, Ulster University, Coleraine BT52 1SA, UK
Author to whom correspondence should be addressed.
Received: 7 October 2016 / Revised: 4 November 2016 / Accepted: 7 November 2016 / Published: 11 November 2016
(This article belongs to the Special Issue B-Vitamins and One-Carbon Metabolism)
View Full-Text   |   Download PDF [700 KB, uploaded 11 November 2016]   |  


Hypertension, a major risk factor for heart disease and stroke, is the world’s leading cause of preventable, premature death. A common polymorphism (677C→T) in the gene encoding the folate metabolizing enzyme methylenetetrahydrofolate reductase (MTHFR) is associated with increased blood pressure, and there is accumulating evidence demonstrating that this phenotype can be modulated, specifically in individuals with the MTHFR 677TT genotype, by the B-vitamin riboflavin, an essential co-factor for MTHFR. The underlying mechanism that links this polymorphism, and the related gene-nutrient interaction, with hypertension is currently unknown. Previous research has shown that 5-methyltetrahydrofolate, the product of the reaction catalysed by MTHFR, appears to be a positive allosteric modulator of endothelial nitric oxide synthase (eNOS) and may thus increase the production of nitric oxide, a potent vasodilator. Blood pressure follows a circadian pattern, peaking shortly after wakening and falling during the night, a phenomenon known as ‘dipping’. Any deviation from this pattern, which can only be identified using ambulatory blood pressure monitoring (ABPM), has been associated with increased cardiovascular disease (CVD) risk. This review will consider the evidence linking this polymorphism and novel gene-nutrient interaction with hypertension and the potential mechanisms that might be involved. The role of ABPM in B-vitamin research and in nutrition research generally will also be reviewed. View Full-Text
Keywords: riboflavin; methylenetetrahydrofolate reductase (MTHFR); hypertension; blood pressure; ABPM; DNA methylation riboflavin; methylenetetrahydrofolate reductase (MTHFR); hypertension; blood pressure; ABPM; DNA methylation

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

McMahon, A.; McNulty, H.; Hughes, C.F.; Strain, J.J.; Ward, M. Novel Approaches to Investigate One-Carbon Metabolism and Related B-Vitamins in Blood Pressure. Nutrients 2016, 8, 720.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top